The combination of strong revenue growth, improved R&D efficiency, and maintained guidance suggests RYTELO is gaining commercial traction. Traders should monitor whether 2026 revenue growth accelerates within the guided range and whether cost discipline offsets the cash burn.
GERN drugs
GERN drug pipeline →How the stock moved after the report
BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Feb 25 $1.72entry
- T+1 · 9mo ago −4.07%α −3.52% · $1.65
- T+5 · 9mo ago −14.53%α −13.44% · $1.47
- T+20 · 8mo ago −8.72%α −3.48% · $1.57
- T+60 · 6mo ago −26.74%α −33.69% · $1.26
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Geron Corporation reported strong full-year 2025 financial results with RYTELO net product revenue of $183.6 million, up from $76.5 million in 2024, representing significant year-over-year growth. The company reiterated 2026 revenue guidance of $220–240 million and expects lower operating expenses despite a one-time $17 million restructuring charge in Q4 2025.
Key Financial Metrics
Key Facts
- RYTELO net product revenue was $183.6 million in full-year 2025, up from $76.5 million in 2024 (139.9% YoY growth)
- Q4 2025 revenue was $48.0 million, with demand growing 9% QoQ
- Company reiterated 2026 RYTELO net product revenue guidance of $220–240 million
- Total operating expenses for 2025 were $254.7 million, within prior guidance
- Restructuring charge of $17.0 million in Q4 2025 due to workforce reduction (~1/3 of staff)
- Ended 2025 with $401.1 million in cash, down from $502.9 million in 2024
- R&D expenses decreased to $73.7 million in 2025 from $103.7 million in 2024
Financial Impact
Revenue grew 140% YoY to $183.6M in 2025 with strong Q4 momentum; 2026 revenue guidance implies 19-20% growth at midpoint
Segment Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| RYTELO (imetelstat) | $183.6M | +139.9% |
Risk Factors
- Cash position decreased by ~$100 million year-over-year, raising questions about sustainability if revenue growth slows
- Restructuring may impact execution, especially with one-third of workforce reduced
- Forward guidance is flat to prior year's growth rate despite strong 2025 performance, suggesting potential deceleration
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-068523 |
| Document: d67820d8k.htm | 0001193125-26-068523 |
| Document: 0001193125-26-068523-index-headers.html | 0001193125-26-068523 |
| Document: 0001193125-26-068523-index.html | 0001193125-26-068523 |
| Document: 0001193125-26-068523.txt | 0001193125-26-068523 |
Track record
11 reports on GERN
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $0.9742 Now $0.9400 −3.51% settles Nov 17
- Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $0.9965 to $0.9419 Now $0.9400 −5.67% ▼ −5.48% −3.79% vs SPY
- Nov 4, 202612d ago 8-K Mixed 6/10 No price data
- Nov 4, 202612d ago Press Release Mixed 6/10 Entry $1.08 to $1.02 Now $0.9400 −12.96% ▼ −5.56% −4.64% vs SPY
- Oct 28, 202619d ago 8-K Bearish 6/10 Entry $0.9462 to $0.9501 Now $0.9400 +0.66% ▼ −0.41% −5.14% vs SPY
- Oct 19, 202628d ago Press Release Neutral 2/10 Entry $1.24 to $1.16 Now $0.9400 −24.19% ▼ −6.85% −6.88% vs SPY
- Sep 18, 20268w ago Press Release Neutral 2/10 Entry $1.30 to $1.25 Now $0.9400 −27.69% ▼ −3.85% −2.83% vs SPY
- Apr 22, 202629w ago Press Release Neutral 1/10 Entry $1.55 to $1.52 Now $0.9400 −39.35% ▼ −2.26% −2.31% vs SPY
- Apr 7, 202631w ago DEFA14A Neutral 3/10 Entry $1.71 to $1.69 Now $0.9400 −45.03% ▼ −1.17% −4.69% vs SPY
- Mar 30, 202633w ago Court Ruling Neutral 2/10 Entry $1.41 to $1.74 Now $0.9400 −33.33% ▲ +23.40% +19.10% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers